©2016 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Nephrol. Mar 6, 2016; 5(2): 139-146
Published online Mar 6, 2016. doi: 10.5527/wjn.v5.i2.139
Published online Mar 6, 2016. doi: 10.5527/wjn.v5.i2.139
Major comorbid disease processes associated with increased incidence of acute kidney injury
Salwa Farooqi, Faculty of Health Sciences, McMaster University and St. Joseph’s Healthcare Hamilton, Ontario L8N 4A6, Canada
Jeffrey G Dickhout, Department of Medicine, Division of Nephrology, McMaster University and St. Joseph’s Healthcare Hamilton, Ontario L8N 4A6, Canada
Author contributions: Both authors equally contributed in the synthesis of this paper.
Conflict-of-interest statement: The authors declare no conflicts of interest regarding this manuscript.
Correspondence to: Jeffrey G Dickhout, PhD, Department of Medicine, Division of Nephrology, McMaster University and St. Joseph’s Healthcare Hamilton, 50 Charlton Avenue East, Ontario L8N 4A6, Canada. jdickhou@stjosham.on.ca
Telephone: +1-905-5221155 Fax: +1-905-5406589
Received: September 12, 2015
Peer-review started: September 13, 2015
First decision: November 7, 2015
Revised: November 23, 2015
Accepted: January 27, 2016
Article in press: January 29, 2016
Published online: March 6, 2016
Processing time: 171 Days and 11.2 Hours
Peer-review started: September 13, 2015
First decision: November 7, 2015
Revised: November 23, 2015
Accepted: January 27, 2016
Article in press: January 29, 2016
Published online: March 6, 2016
Processing time: 171 Days and 11.2 Hours
Core Tip
Core tip: In order to prevent, diagnose, and prophylactically treat patients, healthcare providers must identify co-morbidities that significantly increase the likelihood of acute kidney injury (AKI). Any treatments that compromise cardiac output, renal perfusion pressure, and glomerular hemodynamics risk ischemic injury to the kidney. The innate and adaptive immune responses, which are activated by renal epithelial cell necrosis contribute to the progression of AKI. These factors have been shown to be enhanced in diabetes, cancer, cardiac surgery and human immunodeficiency virus acquired immune deficiency syndrome patients.